TetraLogic Pharmaceuticals Corporation

TLOG · OTC
Analyze with AI
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Operating Activities
Net Income-$50-$36-$0-$16
Dep. & Amort.$0$0$0$0
Deferred Tax$15-$1$0-$0
Stock-Based Comp.$6$3$4$0
Change in WC$1-$3$1-$0
Other Non-Cash-$7$4-$18$0
Operating Cash Flow-$35-$32-$13-$16
Investing Activities
PP&E Inv.-$0-$1-$0-$0
Net Acquisitions$0-$13$0$0
Inv. Purchases-$24-$66$0$0
Inv. Sales/Matur.$60$26$0$6
Other Inv. Act.$0$0$0$0
Investing Cash Flow$35-$54-$0$5
Financing Activities
Debt Repay.-$1$44$14$5
Stock Issued$3$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$2$44$63$5
Forex Effect-$0-$0$0$0
Net Chg. in Cash$2-$42$51-$5
Supplemental Information
Beg. Cash$13$55$5$10
End Cash$15$13$55$5
Free Cash Flow-$35-$33-$13-$16
TetraLogic Pharmaceuticals Corporation (TLOG) Financial Statements & Key Stats | AlphaPilot